<p>Meeder Asset Management Inc. 在第三季度增加了对 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的持股，增幅达到 31,029.4%，根据其最近向 SEC 的披露。这家机构投资者在该期间额外购买了 15,825 股后，持有该公司 15,876 股股票。根据其最近的 SEC 文件，Meeder Asset Management Inc. 在 Elevance Health 的持股价值为 5,130,000 美元。</p>
<p>获取 <strong>Elevance Health</strong> 警报：</p>
<ul>
<li>这只 ETF 证明了医疗保健反弹是真实的</li>
</ul>
<p>其他一些对冲基金最近也对该股票的持仓进行了调整。Vanguard Group Inc. 在第二季度将其在 Elevance Health 的持仓提高了 3.2%。Vanguard Group Inc. 目前持有该公司 22,856,898 股股票，价值 8,890,419,000 美元，在上个季度额外购买了 704,790 股。Sanders Capital LLC 在第二季度将其在 Elevance Health 的股份提高了 24.7%。Sanders Capital LLC 目前持有该公司 5,825,208 股股票，价值 2,265,773,000 美元，在上个季度额外购买了 1,152,440 股。Artisan Partners Limited Partnership 在第二季度将其在 Elevance Health 的持股增加了 9.7%。Artisan Partners Limited Partnership 目前持有该公司 3,675,179 股股票，价值 1,429,498,000 美元，在上个季度额外购买了 324,399 股。挪威银行在第二季度购买了 Elevance Health 的新股份，价值 1,148,379,000 美元。最后，The Manufacturers Life Insurance Company 在第二季度将其在 Elevance Health 的持股提高了 30.7%。The Manufacturers Life Insurance Company 目前持有该公司 2,076,668 股股票，价值 807,741,000 美元，在上个季度额外购买了 487,579 股。89.24% 的股票由机构投资者持有。</p>
<h2>Elevance Health 价格表现</h2>
<p>Elevance Health 股票周一开盘价为 372.80 美元。该公司的 50 日移动平均线为 338.20 美元，200 日移动平均线为 327.98 美元。该公司的速动比率为 1.56，流动比率为 1.56，债务与股本比率为 0.71。该公司的市值为 828.5 亿美元，市盈率为 15.24，市盈增长比率为 1.92，贝塔值为 0.51。Elevance Health, Inc. 的 52 周低点为 273.71 美元，52 周高点为 458.75 美元。</p>
<ul>
<li>防御性投资：3 家支付股息的公司报告强劲的第三季度收益</li>
</ul>
<p>Elevance Health (NYSE:ELV - 获取免费报告) 最近在 10 月 21 日星期二发布了季度收益结果。该公司报告第三季度每股收益为 6.03 美元，超出分析师一致预期的 5.03 美元，超出幅度为 1.00 美元。Elevance Health 的股本回报率为 16.17%，净利润率为 2.84%。该公司第三季度的收入为 500.9 亿美元，而分析师预期为 492.6 亿美元。去年同期，该公司每股收益为 8.37 美元。Elevance Health 的季度收入同比增长 12.0%。研究分析师平均预计 Elevance Health, Inc. 本财年将发布 33.96 的每股收益。</p>
<h2>Elevance Health 宣布分红</h2>
<p>该公司最近还宣布了季度分红，已于 12 月 19 日星期五支付。12 月 5 日星期五的股东获得每股 1.71 美元的分红。这相当于年化 6.84 美元的分红和 1.8% 的股息收益率。除息日为 12 月 5 日星期五。Elevance Health 的分红支付比率 (DPR) 目前为 27.96%。</p>
<h2>分析师评级上调与下调</h2>
<ul>
<li>为什么 Centene 股票下跌 40% — 现在是否值得购买</li>
</ul>
<p>几家券商最近对 ELV 发表了评论。摩根大通将 Elevance Health 的目标价从 384.00 美元上调至 394.00 美元，并在 10 月 28 日的研究报告中给予该公司 “增持” 评级。德意志银行重申了 “持有” 评级，并在 12 月 19 日的报告中将 Elevance Health 的目标价设定为 320.00 美元（低于 332.00 美元）。Wolfe Research 将 Elevance Health 的目标价设定为 425.00 美元，并在周四的研究报告中给予该股票 “跑赢大盘” 评级。瑞穗证券在周五的研究报告中将 Elevance Health 的目标价设定为 413.00 美元。最后，摩根士丹利在 12 月 17 日的研究报告中将 Elevance Health 的目标价从 359.00 美元下调至 352.00 美元，并对该股票给予 “持平” 评级。十三位投资分析师对该股票给予了买入评级，十一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com，该股票目前的共识评级为 “持有”，共识目标价为 400.85 美元。</p>
<p><strong>查看我们最新的 Elevance Health 股票分析</strong></p>
<h2>Elevance Health 公司简介</h2>
<p>(免费报告)</p>
<p>Elevance Health, Inc NYSE: ELV 是一家总部位于美国的大型健康福利公司，提供广泛的健康保险产品和相关服务。公司总部位于印第安纳波利斯，2022 年从 Anthem, Inc 更名为 Elevance Health，同时继续以既有的州和国家品牌运营面向消费者的健康计划。Gail Boudreaux 担任首席执行官和总裁，领导公司在综合医疗和福利交付方面的战略重点。</p>
<p>Elevance 的核心业务包括为个人、雇主和政府项目（包括 Medicare 和 Medicaid 管理医疗产品）提供医疗和专业健康计划。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 Elevance Health</li>
<li>华尔街 “潜力股” 可能成为 2026 年的第一只股票</li>
<li>开火正式开始……</li>
<li>请勿删除，立即阅读</li>
<li>特朗普计划使用公共法 63-43：请做好准备</li>
<li>巨大的机器人推广正在进行中</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Elevance Health 吗？</h2>
<p>在考虑 Elevance Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而 Elevance Health 并不在名单上。</p>
<p>虽然 Elevance Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Meeder Asset Management Inc. 在第三季度大幅增加了对 Elevance Health, Inc. 的持股，增幅达到 31,029.4%，额外购入了 15,825 股，使其总持股量达到 15,876 股，市值为 513 万美元。其他机构投资者，包括先锋集团和 Sanders Capital 也提高了在 Elevance Health 的持仓。该公司的股票开盘价为 372.80 美元，市值为 828.5 亿美元，市盈率为 15.24。Elevance Health 报告第三季度每股收益为 6.03 美元，超出预期，并宣布每股季度股息为 1.71 美元</p>

<p>Meeder Asset Management Inc. increased its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 31,029.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,876 shares of the company's stock after buying an additional 15,825 shares during the period. Meeder Asset Management Inc.'s holdings in Elevance Health were worth $5,130,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Meeder Asset Management Inc. 在第三季度增加了对 Elevance Health, Inc. (NYSE:ELV - 免费报告) 的持股，增幅达到 31,029.4%，根据其最近向 SEC 的披露。这家机构投资者在该期间额外购买了 15,825 股后，持有该公司 15,876 股股票。根据其最近的 SEC 文件，Meeder Asset Management Inc. 在 Elevance Health 的持股价值为 5,130,000 美元。</p>
</div><p>Get <strong>Elevance Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Elevance Health</strong> 警报：</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这只 ETF 证明了医疗保健反弹是真实的</li>
</ul>
</div><p>A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Elevance Health by 3.2% in the second quarter. Vanguard Group Inc. now owns 22,856,898 shares of the company's stock valued at $8,890,419,000 after purchasing an additional 704,790 shares during the last quarter. Sanders Capital LLC lifted its stake in shares of Elevance Health by 24.7% in the second quarter. Sanders Capital LLC now owns 5,825,208 shares of the company's stock worth $2,265,773,000 after buying an additional 1,152,440 shares in the last quarter. Artisan Partners Limited Partnership increased its holdings in Elevance Health by 9.7% in the 2nd quarter. Artisan Partners Limited Partnership now owns 3,675,179 shares of the company's stock worth $1,429,498,000 after buying an additional 324,399 shares in the last quarter. Norges Bank purchased a new stake in Elevance Health during the 2nd quarter valued at $1,148,379,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Elevance Health by 30.7% in the second quarter. The Manufacturers Life Insurance Company now owns 2,076,668 shares of the company's stock worth $807,741,000 after buying an additional 487,579 shares during the last quarter. 89.24% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也对该股票的持仓进行了调整。Vanguard Group Inc. 在第二季度将其在 Elevance Health 的持仓提高了 3.2%。Vanguard Group Inc. 目前持有该公司 22,856,898 股股票，价值 8,890,419,000 美元，在上个季度额外购买了 704,790 股。Sanders Capital LLC 在第二季度将其在 Elevance Health 的股份提高了 24.7%。Sanders Capital LLC 目前持有该公司 5,825,208 股股票，价值 2,265,773,000 美元，在上个季度额外购买了 1,152,440 股。Artisan Partners Limited Partnership 在第二季度将其在 Elevance Health 的持股增加了 9.7%。Artisan Partners Limited Partnership 目前持有该公司 3,675,179 股股票，价值 1,429,498,000 美元，在上个季度额外购买了 324,399 股。挪威银行在第二季度购买了 Elevance Health 的新股份，价值 1,148,379,000 美元。最后，The Manufacturers Life Insurance Company 在第二季度将其在 Elevance Health 的持股提高了 30.7%。The Manufacturers Life Insurance Company 目前持有该公司 2,076,668 股股票，价值 807,741,000 美元，在上个季度额外购买了 487,579 股。89.24% 的股票由机构投资者持有。</p>
</div><h2>Elevance Health Price Performance</h2>
<div class="lb-trans"><h2>Elevance Health 价格表现</h2>
</div><p>Elevance Health stock opened at $372.80 on Monday. The company's 50 day moving average is $338.20 and its two-hundred day moving average is $327.98. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The firm has a market cap of $82.85 billion, a PE ratio of 15.24, a price-to-earnings-growth ratio of 1.92 and a beta of 0.51. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $458.75.</p>
<div class="lb-trans"><p>Elevance Health 股票周一开盘价为 372.80 美元。该公司的 50 日移动平均线为 338.20 美元，200 日移动平均线为 327.98 美元。该公司的速动比率为 1.56，流动比率为 1.56，债务与股本比率为 0.71。该公司的市值为 828.5 亿美元，市盈率为 15.24，市盈增长比率为 1.92，贝塔值为 0.51。Elevance Health, Inc. 的 52 周低点为 273.71 美元，52 周高点为 458.75 美元。</p>
</div><ul>
<li>Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>防御性投资：3 家支付股息的公司报告强劲的第三季度收益</li>
</ul>
</div><p>Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share for the quarter, beating analysts' consensus estimates of $5.03 by $1.00. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The company had revenue of $50.09 billion for the quarter, compared to analysts' expectations of $49.26 billion. During the same period last year, the firm earned $8.37 earnings per share. Elevance Health's quarterly revenue was up 12.0% on a year-over-year basis. On average, research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Elevance Health (NYSE:ELV - 获取免费报告) 最近在 10 月 21 日星期二发布了季度收益结果。该公司报告第三季度每股收益为 6.03 美元，超出分析师一致预期的 5.03 美元，超出幅度为 1.00 美元。Elevance Health 的股本回报率为 16.17%，净利润率为 2.84%。该公司第三季度的收入为 500.9 亿美元，而分析师预期为 492.6 亿美元。去年同期，该公司每股收益为 8.37 美元。Elevance Health 的季度收入同比增长 12.0%。研究分析师平均预计 Elevance Health, Inc. 本财年将发布 33.96 的每股收益。</p>
</div><h2>Elevance Health Announces Dividend</h2>
<div class="lb-trans"><h2>Elevance Health 宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Friday, December 5th were given a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, December 5th. Elevance Health's dividend payout ratio (DPR) is presently 27.96%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，已于 12 月 19 日星期五支付。12 月 5 日星期五的股东获得每股 1.71 美元的分红。这相当于年化 6.84 美元的分红和 1.8% 的股息收益率。除息日为 12 月 5 日星期五。Elevance Health 的分红支付比率 (DPR) 目前为 27.96%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Centene 股票下跌 40% — 现在是否值得购买</li>
</ul>
</div><p>Several brokerages have recently commented on ELV. JPMorgan Chase &amp; Co. raised their price objective on shares of Elevance Health from $384.00 to $394.00 and gave the company an &#34;overweight&#34; rating in a research report on Tuesday, October 28th. Deutsche Bank Aktiengesellschaft reiterated a &#34;hold&#34; rating and issued a $320.00 price target (down from $332.00) on shares of Elevance Health in a report on Friday, December 19th. Wolfe Research set a $425.00 price target on Elevance Health and gave the stock an &#34;outperform&#34; rating in a research report on Thursday. Mizuho set a $413.00 price target on shares of Elevance Health in a research report on Friday. Finally, Morgan Stanley cut their price target on shares of Elevance Health from $359.00 to $352.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Wednesday, December 17th. Thirteen investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $400.85.</p>
<div class="lb-trans"><p>几家券商最近对 ELV 发表了评论。摩根大通将 Elevance Health 的目标价从 384.00 美元上调至 394.00 美元，并在 10 月 28 日的研究报告中给予该公司 “增持” 评级。德意志银行重申了 “持有” 评级，并在 12 月 19 日的报告中将 Elevance Health 的目标价设定为 320.00 美元（低于 332.00 美元）。Wolfe Research 将 Elevance Health 的目标价设定为 425.00 美元，并在周四的研究报告中给予该股票 “跑赢大盘” 评级。瑞穗证券在周五的研究报告中将 Elevance Health 的目标价设定为 413.00 美元。最后，摩根士丹利在 12 月 17 日的研究报告中将 Elevance Health 的目标价从 359.00 美元下调至 352.00 美元，并对该股票给予 “持平” 评级。十三位投资分析师对该股票给予了买入评级，十一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com，该股票目前的共识评级为 “持有”，共识目标价为 400.85 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Elevance Health</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Elevance Health 股票分析</strong></p>
</div><h2>Elevance Health Profile</h2>
<div class="lb-trans"><h2>Elevance Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.</p>
<div class="lb-trans"><p>Elevance Health, Inc NYSE: ELV 是一家总部位于美国的大型健康福利公司，提供广泛的健康保险产品和相关服务。公司总部位于印第安纳波利斯，2022 年从 Anthem, Inc 更名为 Elevance Health，同时继续以既有的州和国家品牌运营面向消费者的健康计划。Gail Boudreaux 担任首席执行官和总裁，领导公司在综合医疗和福利交付方面的战略重点。</p>
</div><p>Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.</p>
<div class="lb-trans"><p>Elevance 的核心业务包括为个人、雇主和政府项目（包括 Medicare 和 Medicaid 管理医疗产品）提供医疗和专业健康计划。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Elevance Health</li>
<li>Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026</li>
<li>Shots officially fired…</li>
<li>Do not delete, read immediately</li>
<li>Trump Planning to Use Public Law 63-43: Prepare Now</li>
<li>Huge robotics rollout underway</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Elevance Health</li>
<li>华尔街 “潜力股” 可能成为 2026 年的第一只股票</li>
<li>开火正式开始……</li>
<li>请勿删除，立即阅读</li>
<li>特朗普计划使用公共法 63-43：请做好准备</li>
<li>巨大的机器人推广正在进行中</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ELV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Elevance Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Elevance Health 吗？</h2>
</div><p>Before you consider Elevance Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Elevance Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛市场注意到之前购买的股票……而 Elevance Health 并不在名单上。</p>
</div><p>While Elevance Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Elevance Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Meeder Asset Management Inc. 购入了 15,825 股 Elevance Health, Inc.的股票 $ELV